§ Funding Round
Series D funding round for Antiva Biosciences raising $31M in November 2021
Series D funding round for Antiva Biosciences raising $31M in November 2021
| Investor | Firm Type | Partner |
|---|---|---|
Adjuvant CapitalLEAD | Organization | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Canaan Partners | — | — |
Dong-A ST | — | — |
| Organization | — | |
| Organization | — | |
HBM Healthcare Investments | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — |
This company has completed 6 funding rounds. Current round is highlighted.
Total Raised
$138.3M
Top Valuation
-
Antiva Biosciences raised $31M in a Series D round.
The round was announced on 11/01/21.
The round was led by Adjuvant Capital.
